Orrick Advises Samena Capital and Cenova Capital on Virtus Medical’s US$83 Million Private Equity Financing



Orrick has advised Samena Capital and Cenova Capital on their US$83 million investment in Virtus Medical Holdings, a new premium healthcare platform in Hong Kong.

Samena Capital, a principal investment group focusing on the Subcontinent, Asia, the Middle East and North Africa (collectively, the “SAMENA” region) and Cenova Capital, a leading fund for healthcare and life sciences investments in China, are the private equity sponsors for the formation and launch of Virtus Medical, which merged the practices of more than 20 highly reputable Hong Kong medical practitioners in different specialties. Virtus plans to combine high-end private specialist services with state-of-the-art treatment facilities and services including physiotherapy, wellness, rehabilitation, and a day surgery centre.

The Orrick team advising on this transaction was led by Hong Kong-based M&A and private equity partner Mark Lehmkuhler.  The Orrick team worked closely with the in-house legal team at Samena Capital, led by Dr. Markus A. Federle, Senior Managing Director and General Counsel of Samena Capital.